July 1, 2006

Age and Apolipoprotein E*4 Allele Effects on Cerebrospinal Fluid β-Amyloid 42 in Adults With Normal Cognition

Key Points

Key points are not available for this paper at this time.

Abstract

These CSF A beta 42 findings are consistent with acceleration by the APOE*4 allele of pathogenic A beta 42 brain deposition starting in later middle age in persons with normal cognition.

Bookmark

Cite This Study

Peskind et al. (Sat,) studied this question.

synapsesocial.com/papers/69d75249f07a12db70b8aa1c https://doi.org/https://doi.org/10.1001/archneur.63.7.936

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp <sub>717</sub> ) Mutants1994 · 1,469 citations
2Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type1997 · 1,643 citations
3Apolipoprotein E ϵ4 Count Affects Age at Onset of Alzheimer Disease,but Not Lifetime Susceptibility2004 · 172 citations
4Apolipoprotein E: Diversity of Cellular Origins, Structural and Biophysical Properties, and Effects in Alzheimer's Disease2004 · 238 citations
5Genotyping and sequence analysis of apolipoprotein E isoforms*11988 · 301 citations